Fosmanogepix is a first-in-class antifungal treatment candidate with a novel mechanism of action. It is available in intravenous and oral formulations and has been evaluated for efficacy and safety in ...

Antibiotic resistance is a global public health threat. Modern health systems rely on antibiotics to prevent and treat ...

The return on investment is low, and many large pharmaceutical companies have abandoned the field. According to the authors, ...

The return on investment is low, and many large pharmaceutical companies have abandoned the field. According to the authors, collaboration and risk-sharing can help keep companies in anti-infective ...

Farm Animal Drug Market reaching a valuation of USD 33,211.3 million by 2034 at a Compound Annual Growth Rate (CAGR) of 5.5%.

A new nationwide Danish study published in The Lancet Psychiatry found that individuals with schizophrenia spectrum disorders ...

A new Lancet study forecast what may happen over the next 25 years if more isn't done to address antimicrobial resistant ...

Chennai: Indian pharma companies in the US generic business reported robust growth in the first quarter of FY25. The growth ...

F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop treatments for infections ...

F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop treatments for infections ...

The following is a summary of “Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders ...

FDA Decision Expected by PDUFA Goal Date of October 25, 2024Potential to be First Oral Penem Approved in the U.S.DUBLIN and CHICAGO, Sept. 10, ...